about
WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcomaWISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis.BL-038, a Benzofuran Derivative, Induces Cell Apoptosis in Human Chondrosarcoma Cells through Reactive Oxygen Species/Mitochondrial Dysfunction and the Caspases Dependent Pathway.Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.p53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure.Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300.Right- and left-sided colorectal cancers respond differently to traditional Chinese medicine.Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth.Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo.Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapyUse of Cyclodextrins in Anticancer Photodynamic Therapy Treatment
P2860
Q33815842-652CBFEC-A896-4673-8EE0-00868D13312AQ33889280-7E2D84B9-B0CC-4014-9C42-451B01686A66Q37286488-53BB9B54-4417-43D5-B6ED-7B605BEE6782Q37603290-F0A57AB2-9B8C-4013-AA77-58049464F670Q38769690-221BB76C-8FBC-464B-9497-FD9C23AC780BQ40087864-410AF231-9E92-4CB3-9E34-DE9159193E79Q41455305-BC2852B9-3371-4583-92A6-CE608ABC45E3Q41832575-153895C6-49F5-4183-A9D1-88A18B511B29Q45365003-00C654DB-4678-4CB4-B27E-DA94E8387A61Q47095623-86387446-AD56-456E-9B69-B06AF03224F2Q48218832-D7EB38D2-72DF-4B10-BA40-7060A53344CEQ50129481-48A5A727-DB0B-4D89-B771-CE69F64F399AQ52684454-28E74131-E399-4F2F-97FD-EA665D21C740Q57367727-0724AB87-0760-45EC-8697-9D2F867ECDC5Q58692471-60D2BFB6-6A48-4994-93AC-623F8E0B77B1
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
An overview of targeted cancer therapy.
@en
type
label
An overview of targeted cancer therapy.
@en
prefLabel
An overview of targeted cancer therapy.
@en
P2860
P1433
P1476
An overview of targeted cancer therapy.
@en
P2093
Viswanadha Vijaya Padma
P2860
P356
10.7603/S40681-015-0019-4
P577
2015-11-28T00:00:00Z